Suppr超能文献

促性腺激素释放激素强效拮抗类似物(地瑞林)对卵泡发育的抑制作用

Inhibition of follicular development by a potent antagonistic analog of gonadotropin-releasing hormone (detirelix).

作者信息

Marshall L A, Fluker M R, Jaffe R B, Monroe S E

机构信息

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco 94143.

出版信息

J Clin Endocrinol Metab. 1991 Apr;72(4):927-33. doi: 10.1210/jcem-72-4-927.

Abstract

The ability of a potent long-acting antagonistic analog of GnRH to suppress gonadotropin secretion, disrupt follicular development, and inhibit ovulation was studied in six women with normal menstrual cycles. The GnRH antagonist detirelix ([N-Ac-D-Nal(2)1,D-pCl-Phe2,D-Trp3,D-hArg(Et2)6,D-Ala10++ +] GnRH; Syntex Research) was administered to six women by sc injection on alternate days during a 27-day period. Six additional women underwent blood sampling only, without receiving detirelix. Within 8 h after the initial injection of detirelix, mean (+/- SEM) serum LH and FSH concentrations decreased by 74 +/- 2% and 26 +/- 3%, respectively. Mean immunoreactive FSH levels, however, returned to baseline after the first 72 h despite continued administration of detirelix. Mean estradiol (E2) concentrations decreased from 165 +/- 15 to 70 +/- 11 pmol/L in the first 24 h. During the treatment period follicular development was inhibited, and none of the six volunteers showed evidence of ovulation, as assessed by serum progesterone (P) levels. Maximal suppression of serum LH and E2 was observed approximately 24 h after each injection of detirelix. Compared to the control volunteers, those receiving detirelix had significantly lower mean serum LH (P less than 0.001), E2 (P less than 0.001), and P (P less than 0.001) levels during treatment; mean FSH concentrations, however, were not statistically different in the treatment and control groups. Rapid recovery of pituitary-ovarian function occurred after completion of treatment. In all six volunteers receiving detirelix, a LH surge occurred 10-16 days after the final injection, followed by increased P levels (greater than 32 nmol/L), indicating ovulation and a luteal phase of normal duration (12-14 days). Detirelix injections elicited local skin reactions (erythema and pruritus), but no systemic side-effects were observed. Thus, this long-acting GnRH antagonist can rapidly suppress gonadotropin secretion, inhibit follicular development, and prevent ovulation.

摘要

在6名月经周期正常的女性中,研究了一种强效长效促性腺激素释放激素(GnRH)拮抗类似物抑制促性腺激素分泌、干扰卵泡发育和抑制排卵的能力。在27天的时间里,每隔一天通过皮下注射将GnRH拮抗剂地加瑞克([N - 乙酰 - D - 萘丙氨酸(2)1,D - 对氯苯丙氨酸2,D - 色氨酸3,D - 高精氨酸(乙基)6,D - 丙氨酸10 +++ ]GnRH;先灵葆雅研究所)给予6名女性。另外6名女性仅进行血样采集,未接受地加瑞克。在首次注射地加瑞克后的8小时内,血清促黄体生成素(LH)和促卵泡生成素(FSH)的平均(±标准误)浓度分别下降了74±2%和26±3%。然而,尽管持续注射地加瑞克,平均免疫反应性FSH水平在最初72小时后恢复到基线。在最初24小时内,平均雌二醇(E2)浓度从165±15降至70±11 pmol/L。在治疗期间,卵泡发育受到抑制,通过血清孕酮(P)水平评估,6名志愿者均未显示排卵迹象。每次注射地加瑞克后约24小时观察到血清LH和E2的最大抑制。与对照志愿者相比,接受地加瑞克的志愿者在治疗期间血清LH(P<0.001)、E2(P<0.001)和P(P<0.001)的平均水平显著较低;然而,治疗组和对照组的平均FSH浓度在统计学上无差异。治疗结束后垂体 - 卵巢功能迅速恢复。在所有6名接受地加瑞克的志愿者中,最后一次注射后10 - 16天出现LH峰,随后P水平升高(大于32 nmol/L),表明排卵且黄体期持续时间正常(12 - 14天)。地加瑞克注射引起局部皮肤反应(红斑和瘙痒),但未观察到全身副作用。因此,这种长效GnRH拮抗剂可迅速抑制促性腺激素分泌、抑制卵泡发育并防止排卵。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验